104 related articles for article (PubMed ID: 20224653)
41. Successful delivery after planned discontinuation of imatinib in a patient with chronic myeloid leukemia.
Kobayashi K; Takebayashi C; Miyata S; Narimatsu H; Kami M
Intern Med; 2009; 48(5):369-71. PubMed ID: 19252364
[TBL] [Abstract][Full Text] [Related]
42. [Imatinib mesylate (Glivec) in treatment of chronic phase chronic myeloid leukemia].
Voglová J; Poznarová A; Chrobák L; Rabasová J; Beránek M; Moravcová J; Faber E; Klamová H; Cikhart M
Vnitr Lek; 2004 Jan; 50(1):21-3, 26-9. PubMed ID: 15015226
[TBL] [Abstract][Full Text] [Related]
43. Imatinib mesylate for Philadelphia chromosome-positive, chronic-phase myeloid leukemia after failure of interferon-alpha: follow-up results.
Kantarjian HM; Talpaz M; O'Brien S; Smith TL; Giles FJ; Faderl S; Thomas DA; Garcia-Manero G; Issa JP; Andreeff M; Kornblau SM; Koller C; Beran M; Keating M; Rios MB; Shan J; Resta D; Capdeville R; Hayes K; Albitar M; Freireich EJ; Cortes JE
Clin Cancer Res; 2002 Jul; 8(7):2177-87. PubMed ID: 12114418
[TBL] [Abstract][Full Text] [Related]
44. [Dasatinib treatment of imatinib-resistant and imatinib-intolerant patients with chronic myeloid leukemia in a chronic phase].
Vinogradova OIu; Turkina AG; Vorontsova AV; Chelysheva EIu; Gusarova GA; Kuznetsov SV; Goriacheva SR; Sokolova MA; Abakumov EM; Stakhina OV; Domracheva EV; Misiurin AV; Khoroshko ND
Ter Arkh; 2009; 81(7):41-6. PubMed ID: 19708572
[TBL] [Abstract][Full Text] [Related]
45. Successful childbirth in a patient with chronic myelogenous leukemia treated with imatinib mesylate during early pregnancy.
Skoumalova I; Vondrakova J; Rohon P; Rozmanova S; Jarosova M; Indrak K; Prochazka M; Santava A; Faber E
Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub; 2008 Jun; 152(1):121-3. PubMed ID: 18795086
[TBL] [Abstract][Full Text] [Related]
46. New strategies in controlling drug resistance in chronic myeloid leukemia.
Frame D
Am J Health Syst Pharm; 2007 Dec; 64(24 Suppl 15):S16-21. PubMed ID: 18056927
[TBL] [Abstract][Full Text] [Related]
47. Imatinib use during pregnancy and breast feeding: a case report and review of the literature.
Ali R; Ozkalemkas F; Kimya Y; Koksal N; Ozkocaman V; Gulten T; Yorulmaz H; Tunali A
Arch Gynecol Obstet; 2009 Aug; 280(2):169-75. PubMed ID: 19083009
[TBL] [Abstract][Full Text] [Related]
48. Response to treatment in women with chronic myeloid leukemia during pregnancy and after delivery.
Klamová H; Marková M; Moravcová J; Sisková M; Cetkovský P; Machová Poláková K
Leuk Res; 2009 Nov; 33(11):1567-9. PubMed ID: 19580997
[TBL] [Abstract][Full Text] [Related]
49. [A case report of refractory pleural effusion associated with dasatinib in the treatment of chronic myeloied leukemia].
Zhang ZC; Qaio JH; Ai HS
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2015 Apr; 23(2):401-6. PubMed ID: 25948193
[TBL] [Abstract][Full Text] [Related]
50. [Hemorrhagic colitis caused by dasatinib following cytomegalovirus enterocolitis in a patient with chronic myelogenous leukemia in the second chronic phase].
Sunami Y; Sato E; Ichikawa K; Yasuda H; Komatsu N
Rinsho Ketsueki; 2011 May; 52(5):282-6. PubMed ID: 21646774
[TBL] [Abstract][Full Text] [Related]
51. Recurrence of Chronic Myeloid Leukemia during Pregnancy Subsequently Achieving Complete Medical Remission.
Mikhael S; Pascoe A; Prezzato J
Case Rep Oncol Med; 2017; 2017():5651064. PubMed ID: 28840048
[TBL] [Abstract][Full Text] [Related]
52. Chronic Myeloid Leukemia and Cesarean Section: The Anesthesiologist's Point of View.
Rebahi H; Ait Sliman M; El Adib AR
Case Rep Obstet Gynecol; 2018; 2018():3138718. PubMed ID: 30319826
[TBL] [Abstract][Full Text] [Related]
53. Pregnancy and Its Successful Outcome in a Patient with Multiple Myeloma.
Garg A; Aggarwal M; Kashyap R
J Obstet Gynaecol India; 2021 Feb; 71(1):78-81. PubMed ID: 33814803
[TBL] [Abstract][Full Text] [Related]
54. Successful pregnancy outcome in a patient of chronic myeloid leukemia without therapy.
Roychowdhury J; Bhattacharyya M; Kumar Kundu A; Panfalia M
J Obstet Gynaecol India; 2011 Oct; 61(5):565-6. PubMed ID: 23024532
[No Abstract] [Full Text] [Related]
55. A case of neurocognitive deficit strongly related to dasatinib therapy.
Chamoun K; Rabinovich E; Baer L; Fastenau P; Lima M
Hematol Transfus Cell Ther; 2020; 42(1):80-82. PubMed ID: 31053490
[No Abstract] [Full Text] [Related]
56. Is she pregnant?
Nuttall G
J R Soc Med; 1998 Apr; 91(4):234. PubMed ID: 20895071
[No Abstract] [Full Text] [Related]
57. Pregnancy Outcomes in Chronic Myeloid Leukemia: A Single Center Experience.
Madabhavi I; Sarkar M; Modi M; Kadakol N
J Glob Oncol; 2019 Sep; 5():1-11. PubMed ID: 31584851
[TBL] [Abstract][Full Text] [Related]
58. Management of chronic myeloid leukemia during pregnancy: a retrospective analysis at a single center.
Moura AC; Delamain MT; Duarte GBO; Lorand-Metze I; Souza CA; Pagnano KBB
Hematol Transfus Cell Ther; 2019; 41(2):125-128. PubMed ID: 31079659
[TBL] [Abstract][Full Text] [Related]
59. Onset of chronic myeloid leukemia with complex karyotype in a pregnant patient: case report and revision of literature.
Sgherza N; Abruzzese E; Perla G; Minervini MM; Chiello V; Sciannamè N; Cascavilla N
Ther Clin Risk Manag; 2017; 13():751-755. PubMed ID: 28721056
[TBL] [Abstract][Full Text] [Related]
60. The impact of dasatinib on pregnancy outcomes.
Cortes JE; Abruzzese E; Chelysheva E; Guha M; Wallis N; Apperley JF
Am J Hematol; 2015 Dec; 90(12):1111-5. PubMed ID: 26348106
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
